Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 6241505)

Published in Chemioterapia on June 01, 1984

Authors

R Piccolomini, N Allocati, G Catamo

Articles by these authors

Coccoid Helicobacter pylori not culturable in vitro reverts in mice. Microbiol Immunol (1994) 1.79

Purification and characterization of three forms of glutathione transferase from Proteus mirabilis. Biochem J (1988) 1.50

Comparative evaluation of the E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents. J Clin Microbiol (1997) 1.50

Helicobacter pylori: a fickle germ. Microbiol Immunol (1994) 1.47

A mixed disulfide bond in bacterial glutathione transferase: functional and evolutionary implications. Structure (1998) 1.29

Influence of temperature on biofilm formation by Listeria monocytogenes on various food-contact surfaces: relationship with motility and cell surface hydrophobicity. J Appl Microbiol (2008) 1.26

Inhibition of Helicobacter pylori by garlic extract (Allium sativum). FEMS Immunol Med Microbiol (1996) 1.13

Glutathione transferase in bacteria: subunit composition and antigenic characterization. J Gen Microbiol (1989) 1.10

Optimal combination of media for primary isolation of Helicobacter pylori from gastric biopsy specimens. J Clin Microbiol (1997) 1.09

Molecular cloning and overexpression of a glutathione transferase gene from Proteus mirabilis. Biochem J (1996) 1.08

Helicobacter pylori isolated from stomach corpus and antrum: comparison of DNA patterns. J Infect (1996) 1.06

The amino acid sequence of glutathione transferase from Proteus mirabilis, a prototype of a new class of enzymes. Eur J Biochem (1993) 1.04

Site-directed mutagenesis of the Proteus mirabilis glutathione transferase B1-1 G-site. FEBS Lett (1998) 1.00

Osteomyelitis and intervertebral discitis caused by Blastoschizomyces capitatus in a patient with acute leukemia. J Clin Microbiol (1994) 0.98

Clinical significance of Actinobacillus actinomycetemcomitans in young individuals during orthodontic treatment. A 3-year longitudinal study. J Clin Periodontol (1997) 0.98

Molecular characterization of virulence determinants of Stenotrophomonas maltophilia strains isolated from patients affected by cystic fibrosis. Int J Immunopathol Pharmacol (2007) 0.96

Purification and characterization of a novel glutathione transferase from Serratia marcescens. Biochim Biophys Acta (1991) 0.94

Site-specific subgingival colonization by Actinobacillus actinomycetemcomitans in orthodontic patients. Am J Orthod Dentofacial Orthop (1999) 0.92

Subinhibitory concentrations of moxifloxacin decrease adhesion and biofilm formation of Stenotrophomonas maltophilia from cystic fibrosis. J Med Microbiol (2010) 0.90

Role of antibiotic sensitivity testing before first-line Helicobacter pylori eradication treatments. Aliment Pharmacol Ther (2003) 0.89

Effect of environmental factors on biofilm formation by clinical Stenotrophomonas maltophilia isolates. Folia Microbiol (Praha) (2007) 0.89

Multiphasic denaturation of glutathione transferase B1-1 by guanidinium chloride. Role of the dimeric structure on the flexibility of the active site. Eur J Biochem (1993) 0.88

Fluids and microbial penetration in the internal part of cement-retained versus screw-retained implant-abutment connections. J Periodontol (2001) 0.87

Bacterial peptide methionine sulphoxide reductase: co-induction with glutathione S-transferase during chemical stress conditions. Biochem J (2001) 0.86

Bacteriostatic and bactericidal in vitro activities of clarithromycin and erythromycin against periodontopathic Actinobacillus actinomycetemcomitans. Antimicrob Agents Chemother (1998) 0.85

Enhanced clearing of Helicobacter pylori after omeprazole plus roxithromycin treatment. FEMS Microbiol Lett (1991) 0.85

Do tonsils represent an extragastric reservoir for Helicobacter pylori infection. J Infect (2001) 0.85

New plate medium for growth and detection of urease activity of Helicobacter pylori. J Clin Microbiol (1992) 0.84

Evaluation of the E test for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from patients with long-term bladder catheterization. J Clin Microbiol (1998) 0.84

Identification of an N-capping box that affects the alpha 6-helix propensity in glutathione S-transferase superfamily proteins: a role for an invariant aspartic residue. Biochem J (1997) 0.83

Evaluation of Staf-Sistem 18-R for identification of staphylococcal clinical isolates to the species level. J Clin Microbiol (1994) 0.83

Characterization of glutathione transferase from Xanthomonas campestris. Arch Biochem Biophys (1993) 0.82

N-terminal region of Proteus mirabilis glutathione transferase is not homologous to mammalian and plant glutathione transferases. FEBS Lett (1989) 0.82

Occurrence of Actinobacillus actinomycetemcomitans in patients wearing orthodontic appliances. A cross-sectional study. J Clin Periodontol (1996) 0.81

The ability of bacteria to use Na-hyaluronate as a nutrient. Acta Ophthalmol Scand (1996) 0.81

In vitro antimicrobial susceptibility of periodontopathic Actinobacillus actinomycetemcomitans to roxithromycin and erythromycin. Oral Microbiol Immunol (1997) 0.80

Laboratory and clinical comparison of preservation media and transport conditions for survival of Actinobacillus actinomycetemcomitans. J Med Microbiol (1998) 0.80

Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies. J Antimicrob Chemother (1994) 0.80

Management and triage of women with human papillomavirus infection in follow-up for low-grade cervical disease: association of HPV-DNA and RNA-based methods. Int J Immunopathol Pharmacol (2007) 0.79

Analysis by limited proteolysis of domain organization and GSH-site arrangement of bacterial glutathione transferase B1-1. Int J Biochem Cell Biol (1995) 0.79

Effect of 2-hydroxyethyl methacrylate on Streptococcus spp. biofilms. Lett Appl Microbiol (2011) 0.79

Staphylococcus pasteuri bacteraemia in a patient with leukaemia. J Clin Pathol (2009) 0.79

Serum and mucosal cytokine profiles in patients with active Helicobacter pylori and ischemic heart disease: is there a relationship? Int J Immunopathol Pharmacol (2007) 0.78

Microbiological evidence of Helicobacter pylori from dental plaque in dyspeptic patients. New Microbiol (1995) 0.78

Enterosistem 18-R: description and comparative evaluation with conventional methods for identification of members of the family Enterobacteriaceae. J Clin Microbiol (1991) 0.78

Slime production by clinical isolates of Blastoschizomyces capitatus from patients with hematological malignancies and catheter-related fungemia. Eur J Clin Microbiol Infect Dis (2004) 0.78

[In vitro antimicrobial activity of glutaraldehyde plus O-phenylphenol association (ratio 2:1)]. Minerva Stomatol (2002) 0.78

Influence of contaminants on the isolation of Helicobacter pylori from gastric biopsy specimens. Eur J Clin Microbiol Infect Dis (1997) 0.78

In vitro interaction of penicillins and cephalosporins with human placenta GSH S-transferase. Res Commun Chem Pathol Pharmacol (1984) 0.78

Bacterial and viral DNA in periodontal disease: a study using multiplex PCR. New Microbiol (2004) 0.78

Crystallization and preliminary X-ray analysis of a bacterial glutathione transferase. Acta Crystallogr D Biol Crystallogr (1996) 0.77

Addition of teicoplanin or vancomycin for the treatment of documented bacteremia due to gram-positive cocci in neutropenic patients with hematological malignancies: microbiological, clinical and economic evaluation. Chemotherapy (2004) 0.77

Absence of Helicobacter pylori in tonsillar swabs from dyspeptic patients. New Microbiol (2000) 0.77

Microbiological and biochemical effectiveness of an antiseptic gel on the bacterial contamination of the inner space of dental implants: a 3-month human longitudinal study. Int J Immunopathol Pharmacol (2010) 0.76

In vitro Staphylococcus epidermidis growth in some viscoelastic substances containing sodium hyaluronate. Ophthalmologica (1998) 0.76

[The in vitro sensitivity of Bacteroides gingivalis and Bacteroides intermedius to different classes of antibiotic chemical molecules]. Minerva Stomatol (1990) 0.76

Prevalence of Actinobacillus actinomycetemcomitans and clinical conditions in children and adolescents from rural and urban areas of central Italy. J Clin Periodontol (2000) 0.76

Detection of Helicobacter pylori by PCR on gastric biopsy specimens taken for CP test: comparison with histopathological analysis. Int J Immunopathol Pharmacol (2004) 0.76

Comparative in vitro activities of 13 antimicrobial agents against Morganella-Proteus-Providencia group bacteria from urinary tract infections. Antimicrob Agents Chemother (1987) 0.76

E-test method for detecting antibiotic synergy against Pseudomonas aeruginosa from neutropenic patients: a cost-effective approach. New Microbiol (2004) 0.75

In vitro viability of external eye microbial flora in hydroxy-propyl-methylcellulose. Ophthalmologica (1999) 0.75

Adhesive properties of Proteus genus related to antimicrobial agents resistance. Microbiologica (1987) 0.75

Usefulness of Leifson staining method in diagnosis of Helicobacter pylori infection. J Clin Microbiol (1999) 0.75

VITEK 2 failure in screening Hafnia alvei inducible beta-lactam resistance. J Hosp Infect (2008) 0.75

Failure to detect Helicobacter pylori in nasal mucus in H pylori positive dyspeptic patients. J Clin Pathol (1995) 0.75

[In vitro and in vivo antimicrobial activity of cefuroxime cefamandole and cephalexin on freshly isolated strains of Gram-positive and Gram-negative bacteria]. Boll Soc Ital Biol Sper (1981) 0.75

[In vitro anti-fungal activity of the econazole-ornidazole combination (1:10 ratio)]. Boll Ist Sieroter Milan (1983) 0.75

[Marine pollution: evaluation of bacteriological parameters]. Boll Soc Ital Biol Sper (1986) 0.75

In vitro synergistic activity of some chinolinic compounds combined with beta-lactam antibiotics against gram-positive and gram-negative clinical isolates. Chemotherapy (1985) 0.75

[The production of enzymes inactivating various antibiotics obtained from Gram-negative bacteria recently isolated in the province of Chieti]. Boll Soc Ital Biol Sper (1981) 0.75

Purification of a GSH-affinity binding protein from Bacteroides fragilis devoid of glutathione transferase activity. FEMS Microbiol Lett (1991) 0.75

Comparative "in vitro" activity of ciprofloxacin (Bay o9867) and other antimicrobial agents against urinary bacterial isolates. Chemioterapia (1986) 0.75

[Study of the action of combinations of beta-lactam antibiotics on the beta-lactamase produced by strains of Enterobacteriaceae]. Boll Soc Ital Biol Sper (1976) 0.75

["In vitro" and "in vivo" antibacterial activity of a new synthetic antibiotic cinoxacin]. Boll Soc Ital Biol Sper (1979) 0.75

[Synergistic properties of quinolinium compounds with broad spectrum antibiotics]. G Ital Chemioter (1984) 0.75

[Study of the microbiological activity in vitro of BB-K-8, a new aminoglycoside antibiotic]. Boll Soc Ital Biol Sper (1976) 0.75

[Amoxicillin: microbiological activity in vitro and in vivo (author's transl)]. Antibiotica (1975) 0.75

[Sensitivity of various species of Proteus to antimicrobial drugs]. G Ital Chemioter (1984) 0.75

[Evaluation of the antibacterial activity in vitro of various cephalosporins on different gram-negative bacterial species of recent clinical isolation]. Boll Soc Ital Biol Sper (1980) 0.75

[In vitro and in vivo antibacterial activity of cephapirin-dicloxacillin combination in the ratio 1:1]. Boll Soc Ital Biol Sper (1980) 0.75

In vitro synergism of nalidixic acid with other broad spectrum antibiotics. Chemioterapia (1984) 0.75

[The in vitro and in vivo antibacterial activity of amoxicillin-flucloxacillin combination (1:1 ratio)]. Antibiotica (1974) 0.75

In vitro and in vivo microbiological evaluations of cefoperazone. Clin Ther (1980) 0.75